AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Sherlock Biosciences Announces Two Upcoming December Conferences

December 2, 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 2, 2019--

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that it will attend the following two conferences in December:

About Sherlock Biosciences

Sherlock Biosciences is dedicated to making molecular diagnostics better, faster and more affordable through Engineering Biology platforms. The company is developing applications of SHERLOCK™, a CRISPR-based method to detect and quantify specific genetic sequences, and INSPECTR TM, a Synthetic Biology-based molecular diagnostics platform that is instrument free. SHERLOCK and INSPECTR can be used in virtually any setting without complex instrumentation, opening up a wide range of potential applications in areas including precision oncology, infection identification, food safety, at-home tests, and disease detection in the field. For more information visit Sherlock.bio.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191202005207/en/

CONTACT: Katie Engleman

1AB

katie@1abmedia.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Sherlock Biosciences

Copyright Business Wire 2019.

PUB: 12/02/2019 08:30 AM/DISC: 12/02/2019 08:30 AM

http://www.businesswire.com/news/home/20191202005207/en